| Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ... The Lancet 393 (10166), 40-50, 2019 | 1237 | 2019 |
| Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology DG Pfister, S Spencer, D Adelstein, D Adkins, Y Anzai, DM Brizel, ... Journal of the National Comprehensive Cancer Network 18 (7), 873-898, 2020 | 963 | 2020 |
| Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy … PF Nguyen-Tan, Q Zhang, KK Ang, RS Weber, DI Rosenthal, D Soulieres, ... Journal of Clinical Oncology 32 (34), 3858-3867, 2014 | 520 | 2014 |
| Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States CT Murphy, TJ Galloway, EA Handorf, BL Egleston, LS Wang, R Mehra, ... Journal of Clinical Oncology 34 (2), 169-178, 2016 | 413 | 2016 |
| NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelines JJ Caudell, ML Gillison, E Maghami, S Spencer, DG Pfister, D Adkins, ... Journal of the National Comprehensive Cancer Network 20 (3), 224-234, 2022 | 338 | 2022 |
| Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database CT Murphy, TJ Galloway, EA Handorf, L Wang, R Mehra, DB Flieder, ... Cancer 121 (8), 1204-1213, 2015 | 148 | 2015 |
| Psychological functioning of caregivers for head and neck cancer patients ML Longacre, JA Ridge, BA Burtness, TJ Galloway, CY Fang Oral oncology 48 (1), 18-25, 2012 | 135 | 2012 |
| p16 status, pathologic and clinical characteristics, biomolecular signature, and long‐term outcomes in head and neck squamous cell carcinomas of unknown primary LM Keller, TJ Galloway, T Holdbrook, K Ruth, D Yang, C Dubyk, D Flieder, ... Head & neck 36 (12), 1677-1684, 2014 | 133 | 2014 |
| Management of squamous cancer metastatic to cervical nodes with an unknown primary site TJ Galloway, JA Ridge Journal of Clinical Oncology 33 (29), 3328-3337, 2015 | 125 | 2015 |
| The impact of radiation treatment time on survival in patients with head and neck cancer T Shaikh, EA Handorf, CT Murphy, R Mehra, JA Ridge, TJ Galloway International Journal of Radiation Oncology* Biology* Physics 96 (5), 967-975, 2016 | 101 | 2016 |
| A phase I study of CUDC-101, a multitarget inhibitor of HDACs, EGFR, and HER2, in combination with chemoradiation in patients with head and neck squamous cell carcinoma TJ Galloway, LJ Wirth, AD Colevas, J Gilbert, JE Bauman, NF Saba, ... Clinical Cancer Research 21 (7), 1566-1573, 2015 | 101 | 2015 |
| Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion TJ Galloway, CG Morris, AA Mancuso, RJ Amdur, WM Mendenhall Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 101 | 2005 |
| Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition B Burtness, JE Bauman, T Galloway The lancet oncology 14 (8), e302-e309, 2013 | 92 | 2013 |
| Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis NG Zaorsky, CT Lee, E Zhang, SW Keith, TJ Galloway Radiotherapy and Oncology 125 (1), 13-20, 2017 | 75 | 2017 |
| Patterns of distant metastasis in head and neck cancer at presentation: implications for initial evaluation JC Liu, M Bhayani, K Kuchta, T Galloway, C Fundakowski Oral oncology 88, 131-136, 2019 | 73 | 2019 |
| Head and neck sarcomas: a comprehensive cancer center experience MA Tejani, TJ Galloway, M Lango, JA Ridge, M Von Mehren Cancers 5 (3), 890-900, 2013 | 71 | 2013 |
| The KRAS-variant and cetuximab response in head and neck squamous cell cancer: a secondary analysis of a randomized clinical trial JB Weidhaas, J Harris, D Schaue, AM Chen, R Chin, R Axelrod, ... JAMA oncology 3 (4), 483-491, 2017 | 69 | 2017 |
| Medical communication-related informational need and resource preferences among family caregivers for head and neck cancer patients ML Longacre, TJ Galloway, CF Parvanta, CY Fang Journal of Cancer education 30, 786-791, 2015 | 65 | 2015 |
| Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer MN Lango, B Egleston, C Fang, B Burtness, T Galloway, J Liu, R Mehra, ... Cancer 120 (6), 840-847, 2014 | 64 | 2014 |
| Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer Y Dong, JA Ridge, T Li, MN Lango, TM Churilla, JR Bauman, TJ Galloway Oral oncology 71, 122-128, 2017 | 61 | 2017 |
